Truist upgraded Robert Half to Hold from Sell with an unchanged price target of $72. The analyst says forward earnings estimates for the company, which have been falling for two years, should bottom in the coming quarters. Robert Half’s valuation appears increasingly fair, trading at an in-line multiple on Truist’s “depressed” 2025 estimates, the analyst tells investors in a research note. Among the most cyclical names, Robert Half should be an outperformer in the early stages of an improving temporary labor market, says the firm.